Search

Your search keyword '"Beelen, Dietrich"' showing total 1,655 results
Start Over Author "Beelen, Dietrich"
1,655 results on '"Beelen, Dietrich"'

201. Additional file 1: of Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

Author

Piemontese, Simona, Boumendil, Ariane, Labopin, Myriam, Schmid, Christoph, Ciceri, Fabio, Arcese, William, Koc, Yener, Gulbas, Zafar, Tischer, Johanna, Bruno, Benedetto, Depei Wu, Blaise, Didier, Beelen, Dietrich, Irrera, Giuseppe, Ruggeri, Annalisa, Houhou, Mohamed, Mohty, Mohamad, and Nagler, Arnon

Abstract

Table S1. Characteristic of the 587 patients included in our analysis and the 1065 patients transplanted in the same years in the EBMT centres but not included in the final analysis due to incomplete data. (DOCX 19 kb)

Published
2019
Full Text
View/download PDF

203. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

Author

Michel, Christian, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Neubauer, Andreas, Lauseker, Michael, Krause, Stefan W, Kolb, Hans-Jochem, Hossfeld, Dieter Kurt, Nerl, Christoph, Baerlocher, Gabriela M., Heim, Dominik, Brümmendorf, Tim H, Fabarius, Alice, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Goebeler, Maria-Elisabeth, Hänel, Mathias, Ho, Anthony, Dengler, Jolanta, Falge, Christiane, Möhle, Robert, Kremers, Stephan, Kneba, Michael, Stegelmann, Frank, Köhne, Claus-Henning, Lindemann, Hans-Walter, Waller, Cornelius F, Spiekermann, Karsten, Berdel, Wolfgang E, Müller, Lothar, Edinger, Matthias, Mayer, Jiri, Beelen, Dietrich W, Bentz, Martin, Link, Hartmut, Hertenstein, Bernd, Fuchs, Roland, Wernli, Martin, Schlegel, Frank, Schlag, Rudolf, De Wit, Maike, Trümper, Lorenz, Hebart, Holger, Hahn, Markus, Thomalla, Jörg, Scheid, Christof, Schafhausen, Philippe, Verbeek, Walter, Eckart, Michael J, Gassmann, Winfried, Schenk, Michael, Brossart, Peter, Wündisch, Thomas, Geer, Thomas, Bildat, Stephan, Schäfer, Erhardt, Hasford, Joerg, Hehlmann, Rüdiger, and Pfirrmann, Markus

Subjects
hemic and lymphatic diseases, 610 Medicine & health, neoplasms
Abstract

Standard first-line therapy of chronic myeloid leukemia is treatment with imatinib. In the randomized German Chronic Myeloid Leukemia-Study IV, more potent BCR-ABL inhibition with 800mg (high-dose) imatinib accelerated achievement of a deep molecular remission. However, whether and when a de-escalation of the dose intensity under high-dose imatinib can be safely performed without increasing the risk of losing deep molecular response is unknown. To gain insights into this clinically relevant question, we analyzed the outcome of imatinib dose reductions from 800mg to 400mg daily in the Chronic Myeloid Leukemia-Study IV. Of the 422 patients that were randomized to the 800mg arm, 68 reduced imatinib to 400mg after they had achieved at least a stable major molecular response. 61 of these 68 patients (90%) maintained major molecular remission on imatinib at 400mg. Five of the seven patients, who lost major molecular remission on the imatinib standard dose, regained major molecular remission while still on 400mg imatinib. Only two of 68 patients had to switch to more potent kinase inhibition to regain major molecular remission. Importantly, the lengths of the imatinib high-dose treatment intervals before and after achieving major molecular remission were associated with the probabilities of maintaining major molecular remission with the standard dose of imatinib. Together, data support that a deep molecular remission achieved with high-dose imatinib, can be safely maintained with standard dose in most patients. The study protocol was registered at ClinicalTrials.gov (NCT00055874).

Published
2019
Full Text
View/download PDF

204. MOESM3 of Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Author

Jiří Pavlů, Labopin, Myriam, Niittyvuopio, Riitta, Socié, Gerard, Yakoub-Agha, Ibrahim, Depei Wu, Remenyi, Peter, Passweg, Jakob, Beelen, Dietrich, Aljurf, Mahmoud, Kröger, Nicolaus, Labussière-Wallet, Hélène, Perić, Zinaida, Giebel, Sebastian, Nagler, Arnon, and Mohty, Mohamad

Subjects
hemic and lymphatic diseases
Abstract

Additional file 3. A. Univariate planned sub-analyses performed separately in subgroups of patients transplanted after chemotherapy-based and TBI-based conditioning. Abbreviations: GVHD, graft-versus-host disease; GRFS, GVHD-free and relapse-free survival; LFS, leukemia free survival; MRD, measurable residual disease; NRM, non-relapse mortality; OS, overall survival; RI, relapse incidence. B. Multivariate planned sub-analyses performed separately in subgroups of patients transplanted after chemotherapy-based conditioning (571 patients of whom 382 were MRD negative and 205 MRD positive) and TBI-based conditioning (1943 patients of whom 1278 were MRD negative and 680 MRD positive). Abbreviations: BM, bone marrow; CR, complete remission; CMV, cytomegalovirus; GVHD, graft-versus-host disease; GRFS, GVHD-free and relapse-free survival; KPS, Karnofsky performance score; LFS, leukemia free survival; MRD, measurable residual disease; NRM, non-relapse mortality; OS, overall survival; Ph, Philadelphia chromosome/BCR-ABL gene rearrangement; RI, relapse incidence; TCD, T-cell depletion; UD, unrelated donor.

Published
2019
Full Text
View/download PDF

207. Additional file 1: of Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Author

Saraceni, Francesco, Labopin, Myriam, Brecht, Arne, Kröger, Nicolaus, Eder, Matthias, Tischer, Johanna, Labussière-Wallet, Hélène, Einsele, Hermann, Beelen, Dietrich, Bunjes, Donald, Niederwieser, Dietger, Bochtler, Tilmann, Bipin Savani, Mohty, Mohamad, and Nagler, Arnon

Abstract

Table S1. Post-transplant cell therapy. Table S2. Drug doses in the three conditioning regimens (TBF, FT, FLAMSA). Table S3. Univariate analysis of ATG yes vs no stratified by conditioning regimen. (DOC 110 kb)

Published
2019
Full Text
View/download PDF

208. Additional file 5: of Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

Author

Piemontese, Simona, Boumendil, Ariane, Labopin, Myriam, Schmid, Christoph, Ciceri, Fabio, Arcese, William, Koc, Yener, Gulbas, Zafar, Tischer, Johanna, Bruno, Benedetto, Depei Wu, Blaise, Didier, Beelen, Dietrich, Irrera, Giuseppe, Ruggeri, Annalisa, Houhou, Mohamed, Mohty, Mohamad, and Nagler, Arnon

Abstract

Table S5. EBMT participating centers. (DOCX 20 kb)

Published
2019
Full Text
View/download PDF

209. Interleukin-18 and outcome after allogeneic stem cell transplantation : A retrospective cohort study: Interleukin-18 and post-transplant outcome

Author

Radujkovic, Aleksandar, Kordelas, Lambros, Dai, Hao, Schult, David, Majer-Lauterbach, Joshua, Beelen, Dietrich, Müller-Tidow, Carsten, Dreger, Peter, and Luft, Thomas

Subjects
Medizin
Abstract

Background: Interleukin-18 (IL-18) is involved in endothelial activation and dysfunction, and in the pathogenesis and severity of acute graft-versus-host disease (aGVHD). Its relevance for patient outcome after allogeneic stem cell transplantation (alloSCT) has not yet been comprehensively addressed. Methods: Pre-transplant serum levels of free IL-18 were retrospectively assessed in a cohort of 589 patients (training cohort). Results were validated in 688 patients allografted in a different centre. The primary endpoint was overall survival (OS). Secondary endpoints included incidences of non-relapse mortality (NRM), relapse, and aGVHD. Findings: In the training cohort, higher pre-transplant levels of free IL-18 were significantly associated with worse OS (hazard ratio [HR] per 1-log2 increase, 1.25, P = 0.008) in multivariable models. This was due to a higher hazard of NRM (HR per 1-log2 increase, 1.39, P = 0.001), rather than relapse. The associations of pre-transplant free IL-18 with higher NRM (HR per 1-log2 increase, 1.24, P = 0.02) and shorter OS (HR per 1-log2 increase, 1.22, P = 0.006) were confirmed in the validation cohort. In both cohorts, the correlations of higher pre-transplant free IL-18 serum levels with increased NRM and worse OS were mainly driven by fatal infectious complications. No associations with incidence of aGVHD were observed. Interpretation: Higher pre-transplant levels of free IL-18 were associated with non-relapse and overall mortality after alloSCT. Our results may provide a rationale for prospective studies evaluating IL-18 status and inhibition of IL-18 activity in patients undergoing allografting. CA extern

Published
2019

210. Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years : A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Shimoni, Avichai, Labopin, Myriam, Savani, B., Byrne, Michael, Volin, L., Finke, Jürgen, Niederwieser, Dietger, Ehninger, Gerhard, Blaise, Didier, Beelen, Dietrich, Tabrizi, Reza, Sengeloev, Henrik, Ganser, Arnold, Cornelissen, J.J., Mohty, Mohamad, Nagler, A., and Cornelissen, Jan J.

Subjects
Medizin
Published
2019

219. 94 - Favourable Outcome after Treosulfan Based Conditioning in Patients Undergoing an Allogeneic Hematopoietic Cell Transplantation (alloHCT) for the Treatment of Acute Myleloid Leukaemia (AML): A Subgroup Analysis of the Randomized Phase III MC-Fludt.14/L Trial

Author

Stölzel, Friedrich, Stelljes, Matthias, Beelen, Dietrich Wilhelm, Markiewicz, Miroslaw, Remenyi, Peter, Dreger, Peter, Ciceri, Fabio, Wagner-Drouet, Eva-Maria, Junghanss, Christian, Scheid, Christoph, Patriarca, Francesca, Socié, Gerard, Hilgendorf, Inken, Rambaldi, Alessandro, Schaefer-Eckart, Kerstin, Russo, Domenico, Grigoleit, Goetz, Wulf, Gerald, Basara, Nadezda, Glass, Bertram, Stuhler, Gernot, Bieniaszewska, Maria, Casper, Jochen, Holler, Ernst, Benedetti, Fabio, Iori, Anna Paola, Trenschel, Rudolf, and Bethge, Wolfgang

Published
2022
Full Text
View/download PDF

220. 42 - Favourable Outcome after Treosulfan Based Conditioning of Patients Receiving an Allogeneic Hematopoietic Cell Transplantation (AlloHCT) for the Treatment of a Myelodysplastic Syndrome (MDS)

Author

Stelljes, Matthias, Trenschel, Rudolf, Beelen, Dietrich Wilhelm, Markiewicz, Miroslaw, Wagner, Eva Maria, Bethge, Wolfgang, Remenyi, Peter, Niederwieser, Dietger, Grigoleit, Goetz, Schaefer-Eckart, Kerstin, Stölzel, Friedrich, Ciceri, Fabio, Dreger, Peter, Junghanß, Christian, Holler, Ernst, Rambaldi, Alessandro, Russo, Domenico, Verbeek, Mareike, Casper, Jochen, Patriarca, Francesca, Bieniaszewska, Maria, Glass, Bertram, Scheid, Christoph, Basara, Nadezda, Finke, Jürgen, Hilgendorf, Inken, Labussière-Wallet, Hélène, Stuhler, Gernot, and Schroeder, Thomas

Published
2022
Full Text
View/download PDF

223. Erratum : Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Author

Mathew, Nimitha R, Baumgartner, Francis, Braun, Lukas, O'Sullivan, David, Thomas, Simone, Waterhouse, Miguel, Müller, Tony A, Hanke, Kathrin, Taromi, Sanaz, Apostolova, Petya, Illert, Anna L, Melchinger, Wolfgang, Duquesne, Sandra, Schmitt-Graeff, Annette, Osswald, Lena, Yan, Kai-Li, Weber, Arnim, Tugues, Sonia, Spath, Sabine, Pfeifer, Dietmar, Follo, Marie, Claus, Rainer, Lübbert, Michael, Rummelt, Christoph, Bertz, Hartmut, Wäsch, Ralph, Haag, Johanna, Schmidts, Andrea, Schultheiss, Michael, Bettinger, Dominik, Thimme, Robert, Ullrich, Evelyn, Tanriver, Yakup, Vuong, Giang Lam, Arnold, Renate, Hemmati, Philipp, Wolf, Dominik, Ditschkowski, Markus, Jilg, Cordula, Wilhelm, Konrad, Leiber, Christian, Gerull, Sabine, Halter, Jörg, Lengerke, Claudia, Pabst, Thomas, Schroeder, Thomas, Kobbe, Guido, Rösler, Wolf, Doostkam, Soroush, Meckel, Stephan, Stabla, Kathleen, Metzelder, Stephan K, Halbach, Sebastian, Brummer, Tilman, Hu, Zehan, Dengjel, Joern, Hackanson, Björn, Schmid, Christoph, Holtick, Udo, Scheid, Christof, Spyridonidis, Alexandros, Stölzel, Friedrich, Ordemann, Rainer, Müller, Lutz P, Sicre-de-Fontbrune, Flore, Ihorst, Gabriele, Kuball, Jürgen, Ehlert, Jan E, Feger, Daniel, Wagner, Eva-Maria, Cahn, Jean-Yves, Schnell, Jacqueline, Kuchenbauer, Florian, Bunjes, Donald, Chakraverty, Ronjon, Richardson, Simon, Gill, Saar, Kröger, Nicolaus, Ayuk, Francis, Vago, Luca, Ciceri, Fabio, Müller, Antonia M, Kondo, Takeshi, Teshima, Takanori, Klaeger, Susan, Kuster, Bernhard, Kim, Dennis Dong Hwan, Weisdorf, Daniel, van der Velden, Walter, Dörfel, Daniela, Bethge, Wolfgang, Hilgendorf, Inken, Hochhaus, Andreas, Andrieux, Geoffroy, Börries, Melanie, Busch, Hauke, Magenau, John, Reddy, Pavan, Labopin, Myriam, Antin, Joseph H, Henden, Andrea S, Hill, Geoffrey R, Kennedy, Glen A, Bar, Merav, Sarma, Anita, McLornan, Donal, Mufti, Ghulam, Oran, Betul, Rezvani, Katayoun, Shah, Omid, Negrin, Robert S, Nagler, Arnon, Prinz, Marco, Burchert, Andreas, Neubauer, Andreas, Beelen, Dietrich, Mackensen, Andreas, von Bubnoff, Nikolas, Herr, Wolfgang, Becher, Burkhard, Socié, Gerard, Caligiuri, Michael A, Ruggiero, Eliana, Bonini, Chiara, Häcker, Georg, Duyster, Justus, Finke, Jürgen, Pearce, Erika, Blazar, Bruce R, and Zeiser, Robert

Abstract

This corrects the article DOI: 10.1038/nm.4484.

Published
2018

229. Leukemia relapse following unmanipulated haploidentical transplantation : a risk-factors analysis of on behalf of the Acute Leukemia Working Party of the EBMT

Author

Piemontese, Simona, Boumendil, Arianne, Labopin, Myriam, Schmid, Christoph, Ciceri, Fabio, Arcese, William, Koc, Yener, Gulbas, Zafer, Tischer, Johanna, Bruno, Bendetto, Wu, Depei, Didier Blaise, Beelen, Dietrich, Irrera, Giuseppe, Ruggeri, Annalisa, Houhou, Mohamed, Mohty, Mohamad, and Nagler, Arnon

Subjects
Medizin
Published
2018

230. Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma : A survey of the EBMT lymphoma working party

Author

Sellner, L., Koster, L., Vandenberghe, E., Beelen, Dietrich W., de Groot, M. R., Blaise, D., Valkova, V., Passweg, Jakob, Schoemans, Helene, Ljungman, Per, Müller, Lars P., Wulf, G., van Gelder, M., Wolschke, C., Hunault-Berger, M., Russell, N., Olivieri, A., Schetelig, J., Kröger, N., Montoto, Silvia, Dreger, P., and EBMT Lymphoma Working Party

Subjects
Medizin
Published
2018

232. Transplant-related prediction of survival in primary myelofibrosis : a study by the EBMT

Author

Gagelmann, Nico, Chalandon, Yves, Wang, Junfeng, de Wreede, Liesbeth, Wolschke, Christine, Van Lint, Maria Teresa, Beelen, Dietrich, Socié, Gerard, Stuhler, Gernot, Vitek, Antonin, Ehninger, Gerhard, Niederwieser, Dietger, Einsele, Herman, Markiewicz, Miroslaw, Arnold, Renate, Yakoub-Agha, Ibrahim, Robinson, Stephen, Reményi, Péter, Passweg, Jakob, Sengeloev, Henrik, Poiré, Xavier, Petersen, Eefke, Dreger, Peter, Kröger, Nicolaus, and Robin, Marie

Subjects
Medizin
Published
2018

233. Treosulfan conditioning for allogenic hematopoietic stem cell transplantation in multiple myeloma, advantages for non-relapse mortality and survival, but with high incidence of relapse

Author

Gran, Charlotte, Wang, Junfeng, Nahi, Hareth, Koster, Linda, Einsele, Herman, Itälä-Remes, Maija, Holler, Ernst, Beelen, Dietrich, Ciceri, Fabio, Ehninger, Gerhard, Finke, Jürgen, de Wreede, Liesbeth, Ljungman, Per, Tischer, Johanna, Verbeek, Mareike, Klyuchnikov, Evgeny, Hilgendorf, Inken, Schäfer-Eckart, Kerstin, Scheid, Christof, Bunjes, Donald, Basara, Nadezda, Haenel, Mathias, Müller, Lutz Peter, Biersack, Harald, Gahrton, Gösta, Garderet, Laurent, and Kröger, Nicolaus

Subjects
Medizin
Published
2018

234. Comparison of the outcomes of allogeneic hematopoietic stem cell transplantation from HLA-identical siblings versus unmanipulated haploidentical donors in relapsed or refractory acute myeloid leukemia

Author

Battipaglia, Giorgia, Boumendil, Ariane, Labopin, Myriam, Ruggeri, Annalisa, Ciceri, Fabio, Tischer, Johanna, Steljes, Matthias, Ehninger, Gerhard, Beelen, Dietrich, Finke, Jürgen, Van Lint, Maria Teresa, Ganser, Arnold, Afanasyev, Boris, Fanin, Renato, Mohty, Mohamad, and Nagler, Arnon

Subjects
Medizin
Published
2018

235. Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassified : A Retrospective Study by the Chronic Malignancies Working Party of the EBMT

Author

McLornan, Donal, Szydlo, Richard, Robin, Marie, Koster, Linda, Stuhler, Gernot, Arnold, Renate, Niederwieser, Dietger, Mufti, Ghulam, Beelen, Dietrich, Ganser, Arnold, Radujkovic, Aleks, Bunjes, Donald, Sengeloev, Henrik, Yakoub-Agha, Ibrahim, Malladi, Ram, Aljurf, Mahmoud, Blau, Igor Wolfgang, Kalhs, Peter, Lenhoff, Stig, Campos, Antonio, Wulf, Gerald G., Verbeek, Mareike, Stelljes, Matthias, Beguin, Yves, Chalandon, Yves, and Kroger, Nicolaus

Subjects
Medizin
Published
2018

236. Leitlinie - ICD-10 C92.-, ICD-10 C93.- : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

Author

Schweizerische Gesellschaft Für Hämatologie, Schlenk, Richard Friedrich, Schweizerische Gesellschaft Für Medizinische Onkologie, Gesellschaft Für Pädiatrische Onkologie Und Hämatologie, Niederwieser, Dietger, Reinhardt, Dirk, Österreichische Gesellschaft Für Hämatologie & Medizinische Onkologie, Greil, Richard, Braess, Jan, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Beelen, Dietrich W., Passweg, Jakob R., and Röllig, Christoph

Subjects
Medizin und Gesundheit
Published
2018
Full Text
View/download PDF

237. Comparative outcomes for matched and mismatched (haplo) family donors for Myelodysplastic syndromes

Author

Raj, Kavita, Eikema, Dirk-Jan, Koster, Linda, Van Lint, Maria Teresa, Blaise, Didier, Nagler, Arnon, Beelen, Dietrich, Socié, Gerard, Koc, Yener, Yakoub-Agha, Ibrahim, Mufti, Ghulam.J., Maertens, Johann, Ghavamzadeh, Ardeshir, Chevallier, Patrice, Reményi, Péter, Corral, Lucia Lopez, Ehninger, Gerhard, Meijer, Ellen, Lamy, Thierry, Pérez-Simón, Jose Antonio, Wu, Depei, Robin, Marie, and Kröger, Nicolaus

Subjects
Medizin
Published
2018

239. XplOit - A platform for the development of system medicine driven and machine-learning models in allogeneic stem cell transplantation

Author

Turki, A., Lehr, T., Pfeifer, Nico, Smola, S., Graf, N., Kiefer, S., Ihle, M., Bittenbring, J. T., Schwarz, U., Rissland, J., Rohm, K., Rauch, J., Theobald, S., Och, K., Goetz, K., Handl, L., Bayraktar, E., Brossette, C., Braun, Y., Beelen, Dietrich W., Weiler, G., and XplOit Konsortium

Subjects
Medizin, ComputingMethodologies_GENERAL
Abstract

Poster-Abstract

Published
2018

241. Allogeneic hematopoietic stem cell transplantation (HSCT) beyond first complete remission (CR) in patients with acute myeloid leukemia (AML) : Results from the AMLCG1999 trial

Author

Evers, G., Beelen, Dietrich W., Braess, J., Sauerland, Maria Cristina, Kolb, H. J., Reichle, A., Holler, E., Schwerdtfeger, R., Arnold, R., Scheid, C., Krug, U., Müller-Tidow, C., Schliemann, C., Mikesch, J.-H., Lenz, G., Wörmann, B. J., Hiddemann, W., Berdel, W. E., and Stelljes, M.

Subjects
Medizin
Published
2018

244. Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party

Author

Bazarbachi, Abdul Hamid, primary, Al Hamed, Rama, additional, Labopin, Myriam, additional, Afanasyev, Boris, additional, Hamladji, Rose-Marie, additional, Beelen, Dietrich, additional, Eder, Matthias, additional, Scheid, Christof, additional, Wu, Depei, additional, Bunjes, Donald, additional, Stepensky, Polina, additional, Tischer, Johanna, additional, Kröger, Nicolaus, additional, Peric, Zina, additional, Aljurf, Mahmoud, additional, Giebel, Sebastian, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2019
Full Text
View/download PDF

245. EASIX and mortality after allogeneic stem cell transplantation

Author

Luft, Thomas, primary, Benner, Axel, additional, Terzer, Tobias, additional, Jodele, Sonata, additional, Dandoy, Christopher E., additional, Storb, Rainer, additional, Kordelas, Lambros, additional, Beelen, Dietrich, additional, Gooley, Ted, additional, Sandmaier, Brenda M., additional, Sorror, Mohamed, additional, Zeisbrich, Markus, additional, Radujkovic, Aleksandar, additional, Dreger, Peter, additional, and Penack, Olaf, additional

Published
2019
Full Text
View/download PDF

246. Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation

Author

Mannina, Daniele, primary, Gagelmann, Nico, additional, Badbaran, Anita, additional, Ditschkowski, Markus, additional, Bogdanov, Rashit, additional, Robin, Marie, additional, Cassinat, Bruno, additional, Heuser, Michael, additional, Shahswar, Rabia, additional, Thol, Felicitas, additional, Beelen, Dietrich, additional, and Kröger, Nicolaus, additional

Published
2019
Full Text
View/download PDF

247. Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study

Author

Gatwood, Katie S., primary, Labopin, Myriam, additional, Savani, Bipin N., additional, Finke, Jürgen, additional, Socie, Gerard, additional, Beelen, Dietrich, additional, Yakoub-Agha, Ibrahim, additional, Chevallier, Patrice, additional, Ganser, Arnold, additional, Blaise, Didier, additional, Milpied, Noel, additional, Bruno, Lioure, additional, Mailhol, Audrey, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2019
Full Text
View/download PDF

248. Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Halaburda, Kazimierz, primary, Labopin, Myriam, additional, Mailhol, Audrey, additional, Socié, Gerard, additional, Craddock, Charles, additional, Aljurf, Mahmoud, additional, Beelen, Dietrich, additional, Cornelissen, Jan J., additional, Bourhis, Jean-Henri, additional, Labussière-Wallet, Hélène, additional, Blaise, Didier, additional, Gedde-Dahl, Tobias, additional, Gilleece, Maria, additional, Yakoub-Agha, Ibrahim, additional, Mufti, Ghulam, additional, Esteve, Jordi, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results